Long-Term Report of a Comprehensive Molecular and Genomic Analysis in NRG Oncology/RTOG 0424: A Phase II Study of Radiation and Temozolomide in High-Risk Grade II Glioma.
Fleming JL, Pugh SL, Fisher BJ, Lesser GJ, Macdonald DR, Bell EH, McElroy JP, Becker AP, Timmers CD, Aldape KD, Rogers CL, Doyle TJ, Werner-Wasik M, Bahary JP, Yu HM, D'Souza DP, Laack NN, Sneed PK, Kwok Y, Won M, Mehta MP, Chakravarti A.
Fleming JL, et al. Among authors: macdonald dr.
JCO Precis Oncol. 2021 Sep 1;5:PO.21.00112. doi: 10.1200/PO.21.00112. eCollection 2021.
JCO Precis Oncol. 2021.
PMID: 34589661
Free PMC article.
Clinical Trial.